Key result
Review highlights sex-specific risk factors and circulating biomarkers as therapeutic targets in female stroke.
Stroke has been emerged as one of major health problems for women worldwide. Increasing of knowledge in this field has provided new data in this area which contribute to finding of new risk factors and could improve stroke treatment. A large number studies indicated a variety of risk factors including sex, age, race, smoking, diabetes, and physical inactivity could be involved in stroke in women. The understanding of various aspects involved in women stroke including risk factors, outcomes, stroke recovery, and prevention could provide new therapeutic platforms which could likely lead to better treatment in women stroke. Diagnosis is one of important steps in stroke therapy. It has been showed that a variety of biomarkers such as microRNAs (miRNAs), tPA, and von willebrand factor could be used as therapeutic and diagnostic biomarkers in stroke therapy. Here, we summarized various aspects of stroke in women which could help to recognition risk factors, outcomes, care, treatment, and novel biomarkers involve in treatment of stroke. J. Cell. Biochem. 118: 4191-4202, 2017.
No takes yet. Share an insight, caveat, or question.
Hamed Mirzaei (2017) conducted a review in Stroke in women. Risk factors (sex, age, race, smoking, diabetes, physical inactivity) and clinical biomarkers (miRNAs, tPA, von Willebrand factor) was evaluated. Risk factors (smoking, diabetes, inactivity) and biomarkers (miRNAs, tPA, von Willebrand factor) are reviewed as diagnostic and therapeutic targets in female stroke (no quantitative data reported).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: